Guangbin Sun

Dr. Guangbin Sun

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
JPJiefei Peng
Jiefei Peng
RWranran Wang
ranran Wang
WSWanru Sun
Wanru Sun
MHMinhua Huang
Minhua Huang
RWRong Wang
Rong Wang
SXShuyang Xie
Shuyang Xie
A new and promising anticancer strategy via the use of Au-RGD-miR-320a nanoparticles, and identify miR-320a/Sp1 as a potential target for future systemic therapy against lung cancer.

1 March 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HSHuan-Huan Shen
Huan-Huan Shen
JPJie-Fei Peng
Jie-Fei Peng
RWRan-Ran Wang
Ran-Ran Wang
PWPingyu Wang
Pingyu Wang
JZJia-Xiang Zhang
Jia-Xiang Zhang
SXShuyang Xie
Shuyang Xie
Purpose: The drug resistance and low response rates of immunotherapy limit its application. This study aimed to construct a new nanoparticle (CaCO3-polydopamine-polyethylenimine, CPP) to effectively deliver interleukin-12 (IL-12) and suppress cancer progress through immunotherapy. Methods: The size distribution of CPP and its zeta potential were measured using a Malvern Zetasizer Nano-ZS90. The morphology and electrophoresis tentative delay of CPP were analyzed using a JEM-1400 transmission electron microscope and an ultraviolet spectrophotometer, respectively. Cell proliferation was analyzed by MTT assay. Proteins were analyzed by Western blot. IL-12 and HMGB1 levels were estimated by ELISA kits. Live/dead staining assay was performed using a Calcein-AM/PI kit. ATP production was detected using an ATP assay kit. The xenografts in vivo were estimated in C57BL/6 mice. The levels of CD80+/CD86+, CD3+/CD4+ and CD3+/CD8+ were analyzed by flow cytometry. Results: CPP could effectively express EGFP or IL-12 and increase ROS levels. Laser treatment promoted CPP-IL-12 induced the number of dead or apoptotic cell. CPP-IL-12 and laser could further enhance CALR levels and extracellular HMGB1 levels and decrease intracellular HMGB1 and ATP levels, indicating that it may induce immunogenic cell death (ICD). The tumors and weights of xenografts in CPP-IL-12 or laser-treated mice were significantly reduced than in controls. The IL-12 expression, the CD80+/CD86+ expression of DC from lymph glands, and the number of CD3+/CD8+T or CD3+/CD4+T cells from the spleen increased in CPP-IL-12-treated or laser-treated xenografts compared with controls. The levels of granzyme B, IFN-γ, and TNF-α in the serum of CPP-IL-12-treated mice increased. Interestingly, CPP-IL-12 treatment in local xenografts in the back of mice could effectively inhibit the growth of the distant untreated tumor. Conclusion: The novel CPP-IL-12 could overexpress IL-12 in melanoma cells and achieve immunotherapy to melanoma through inducing ICD, activating CD4+ T cell, and enhancing the function of tumor-reactive CD8+ T cells.

2 May 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
ZWZhuang Wang
Zhuang Wang
SXSen Xu
Sen Xu
JHJinxia Hu
Jinxia Hu
HSHongfang Sun
Hongfang Sun
YYYuan Yu
Yuan Yu
GSGuangbin Sun
Guangbin Sun

13 October 2025 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
GZGuo-Yang Zhang
Guo-Yang Zhang
YQYu-Jie Qiu
Yu-Jie Qiu
JZJia-Xin Zheng
Jia-Xin Zheng
JYJia-Xin Yu
Jia-Xin Yu
JMJun-Yi Ma
Jun-Yi Ma
SXSen Xu
Sen Xu

21 February 2025 in The FASEB Journal
Verified
Journal Article
Closed access
CZChuanfeng Zhang
Chuanfeng Zhang
JWJianing Wang
Jianing Wang
PKPeng Kong
Peng Kong
GSGuangbin Sun
Guangbin Sun
HSHongfang Sun
Hongfang Sun
YYYuan Yu
Yuan Yu